Spok Holdings, Inc. (NASDAQ:SPOK – Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $15.60 and traded as high as $15.99. Spok shares last traded at $15.81, with a volume of 88,988 shares changing hands.
Analysts Set New Price Targets
Separately, StockNews.com upgraded shares of Spok from a “hold” rating to a “buy” rating in a report on Friday, October 25th.
View Our Latest Report on Spok
Spok Stock Performance
Institutional Investors Weigh In On Spok
Large investors have recently modified their holdings of the stock. Sanctuary Advisors LLC boosted its holdings in Spok by 10.8% in the 3rd quarter. Sanctuary Advisors LLC now owns 25,998 shares of the Wireless communications provider’s stock worth $422,000 after buying an additional 2,536 shares during the period. Barclays PLC boosted its holdings in Spok by 273.8% in the 3rd quarter. Barclays PLC now owns 24,078 shares of the Wireless communications provider’s stock worth $362,000 after buying an additional 17,637 shares during the period. JPMorgan Chase & Co. boosted its holdings in Spok by 2,263.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 198,419 shares of the Wireless communications provider’s stock worth $2,988,000 after buying an additional 190,024 shares during the period. BNP Paribas Financial Markets boosted its holdings in Spok by 18.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,837 shares of the Wireless communications provider’s stock valued at $58,000 after purchasing an additional 609 shares during the period. Finally, FMR LLC boosted its holdings in Spok by 39.9% in the 3rd quarter. FMR LLC now owns 14,479 shares of the Wireless communications provider’s stock valued at $218,000 after purchasing an additional 4,130 shares during the period. Hedge funds and other institutional investors own 50.81% of the company’s stock.
About Spok
Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.
Recommended Stories
- Five stocks we like better than Spok
- How to Find Undervalued Stocks
- How to Invest in Small Cap Stocks
- What Are Growth Stocks and Investing in Them
- These Are the Dividend Stocks Insiders Bought in January
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Spok Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spok and related companies with MarketBeat.com's FREE daily email newsletter.